** = Publications listed in SCI/SSCI/Pubmed
** Muin, DA; Kollmann, M; Blatterer, J; Hoermann, G; Husslein, PW; Lafer, I; Petek, E; Schwarzbraun, T
Cardio-pathogenic variants in unexplained intrauterine fetal death: a retrospective pilot study.
Sci Rep. 2021; 11(1): 6737-6737.
Doi: 10.1038/s41598-021-85893-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Lafer, I; Michaelis, S; Schneider, C; Baranyi, A; Schnedl, WJ; Holasek, S; Zelzer, S; Niedrist, T; Meinitzer, A; Enko, D
BETA-TRACE PROTEIN CONCENTRATIONS AT THE BLOOD-CEREBROSPINAL FLUID BARRIER - ACUTE PHASE AFFECTS PROTEIN STATUS
EXCLI J. 2021; 20: 1446-1452.
Doi: 10.17179/excli2021-4148
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ulz, P; Belic, J; Graf, R; Auer, M; Lafer, I; Fischereder, K; Webersinke, G; Pummer, K; Augustin, H; Pichler, M; Hoefler, G; Bauernhofer, T; Geigl, JB; Heitzer, E; Speicher, MR
Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer.
Nat Commun. 2016; 7(15):12008-12008
Doi: 10.1038/ncomms12008
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Heidary, M; Auer, M; Ulz, P; Heitzer, E; Petru, E; Gasch, C; Riethdorf, S; Mauermann, O; Lafer, I; Pristauz, G; Lax, S; Pantel, K; Geigl, JB; Speicher, MR
The dynamic range of circulating tumor DNA in metastatic breast cancer.
Breast Cancer Res. 2014; 16(4):421-421
Doi: 10.1186/s13058-014-0421-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Mohan, S; Heitzer, E; Ulz, P; Lafer, I; Lax, S; Auer, M; Pichler, M; Gerger, A; Eisner, F; Hoefler, G; Bauernhofer, T; Geigl, JB; Speicher, MR
Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing.
PLoS Genet. 2014; 10(3):e1004271-e1004271
Doi: 10.1371/journal.pgen.1004271
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Heitzer, E; Mohan, S; Ulz, P; Lafer, I; Auer, M; Lax, S; Hoefler, G; Bauernhofer, T; Geigl, JB; Speicher, MR;
Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing.
EUR J CANCER. 2014; 50: S96-S96.-EACR 2014; München.
Doi: 10.1016/S0959-8049(14)50357-7
[Poster]
Web of Science
FullText
FullText_MUG
** Heitzer, E; Lax, S; Lafer, I; Müller, SM; Pristauz, G; Ulz, P; Jahn, S; Högenauer, C; Petru, E; Speicher, MR; Geigl, JB
Multiplex genetic cancer testing identifies pathogenic mutations in TP53 and CDH1 in a patient with bilateral breast and endometrial adenocarcinoma.
BMC Med Genet. 2013; 14(1):129-129
Doi: 10.1186/1471-2350-14-129
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Auer, M; Heitzer, E; Ulz, P; Pristauz, G; Petru, E; Jahn, S; Lafer, I; Pantel, K; Speicher, MR; Geigl, JB
Complex tumor genomes inferred from plasma DNA of patients with metastatic breast cancer by whole-genome sequencing
EUR J CANCER. 2013; 49: S399-S399.-17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity; SEP 27-OCT 01, 2013; Amsterdam, NETHERLANDS.
[Oral Communication]
Web of Science
** Binder, JS; Weidemann, F; Schoser, B; Niemann, M; Machann, W; Beer, M; Plank, G; Schmidt, A; Bisping, E; Poparic, I; Lafer, I; Stojakovic, T; Quasthoff, S; Vincent, JB; Rienmueller, R; Speicher, MR; Berghold, A; Pieske, B; Windpassinger, C
Spongious hypertrophic cardiomyopathy in patients with mutations in the four-and-a-half LIM domain 1 gene.
Circ Cardiovasc Genet. 2012; 5(5):490-502
Doi: 10.1161/CIRCGENETICS.111.962332
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Reininghaus, EZ; Schmidt, H; Lafer, I; Gutjahr, G; Schmidt, SM; Reininghaus, B; Kapfhammer, HP; Stepan, V
Outcome of coumarin-therapy in an outpatient setting over a 10-year period: coumarin-therapy in clinical practice.
Wien Klin Wochenschr. 2012; 124(21-22):756-762
Doi: 10.1007/s00508-012-0254-6
Web of Science
PubMed
FullText
FullText_MUG
** Binder, J; Weidemann, F; Beer, M; Machann, W; Niemann, M; Plank, G; Lafer, I; Quasthoff, S; Stojakovic, T; Windpassinger, C
SPONGIOUS HYPERTROPHIC CARDIOMYOPATHY: A NOVEL PHENOTYPE OF HYPERTROPHIC CARDIOMYOPATHY IN PATIENTS WITH MUTATIONS IN THE FOUR-AND-A-HALF LIM-DOMAIN 1 GENE.
J AM COLL CARDIOL. 2012; 59(13):E1579-E1579.-61st Annual Scientific Session and Expo of the American College of Cardiology (ACC); MAR 24-27, 2012; Chicago, IL, USA.
Doi: 10.1016/S0735-1097(12)61580-0
[Poster]
Web of Science
FullText
FullText_MUG